Pharmacogenetics and immunosuppressive drugs in solid organ transplantation

被引：0
|
作者：
Teun van Gelder
Ron H. van Schaik
Dennis A. Hesselink
机构：
[1] Erasmus MC,Department of Hospital Pharmacy
[2] University Medical Center Rotterdam,Department of Clinical Chemistry
[3] Erasmus MC,Department of Internal Medicine
[4] University Medical Center Rotterdam,undefined
[5] Erasmus MC,undefined
[6] University Medical Center Rotterdam,undefined
来源：
Nature Reviews Nephrology | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The prediction made 15 years ago that pharmacogenetics would revolutionize pharmacotherapy has not materializedFor several immunosuppressive drugs, studies show significant associations between polymorphisms in genes encoding metabolizing enzymes and pharmacokinetic dataStudies showing a clinical benefit if immunosuppressive drug dose is based on pharmacogenetic data are lackingEfficient therapeutic drug monitoring can rapidly correct for deviations in drug exposureTreatment algorithms that include polymorphisms in genes encoding pharmacodynamic parameters, drug transporter proteins, and predictors of toxicity will provide additional benefit
引用
收藏
页码：725 / 731
页数：6
相关论文
共 50 条
  • [41] Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients
    Andrews, Louise M.
    Riva, Natalia
    de Winter, Brenda C.
    Hesselink, Dennis A.
    de Wildt, Saskia N.
    Cransberg, Karlien
    van Gelder, Teun
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (06) : 921 - 936
  • [42] The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation
    Gibson, Caitlin M.
    Childs-Kean, Lindsey M.
    Naziruddin, Zahra
    Howell, Crystal K.
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (01)
  • [43] Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy
    Taylor, AL
    Watson, CJE
    Bradley, JA
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (01) : 23 - 46
  • [44] Immunosuppressive Therapy in Solid Organ Transplantation Primer for Radiologists and Potential Complications
    Tammisetti, Varaha Sai
    Prasad, Srinivasa R.
    Dasyam, Navya
    Menias, Christine O.
    Katabathina, Venkata
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2023, 61 (05) : 913 - 932
  • [45] Immunosuppressive agents in organ transplantation
    Magee, CC
    Denton, MD
    Milford, EL
    HOSPITAL MEDICINE, 1999, 60 (05): : 364 - 369
  • [46] The Influence of Immunosuppressive Drugs On the Epithelial Microenvironment in Solid Organ Transplantation - Identification of Biomarker Candidates for Rejection Vs. Tolerance
    Akhdar, A.
    Mueller, B.
    Neudoerfl, C.
    Lehner, F.
    Stevanovic-Meyer, M.
    Daemen, K.
    Keil, J.
    Haller, H.
    Blume, C.
    Falk, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [47] IMMUNOSUPPRESSIVE DRUGS AND TRANSPLANTATION PROTOCOLS
    Maria Leon, Lina
    Gonzalez Garcia, Elena
    Ovidia Lopez, Maria
    Afonso, Sara
    Jose Santana, Ma
    Jimenez, Carlos
    ARCHIVOS ESPANOLES DE UROLOGIA, 2021, 74 (10): : 1002 - 1012
  • [48] IMMUNOSUPPRESSIVE DRUGS MODULATE THE MICROENVIRONMENT IN SOLID ORGAN TRANSPLANTATION BY SUPPRESSING THE MTOR SIGNALING PATHWAY AND CHEMOKINE SECRETION IN PRIMARY HUMAN HEPATOCYTES
    Akhdar, A.
    Mueller, B.
    Neudoerfl, C.
    Meyer, M. Stevanovic
    Daemen, K.
    Keil, J.
    Zierau, A.
    Lehner, F.
    Vondran, F.
    Falk, C.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 43 - 43
  • [49] Nonadherence to immunosuppressive therapy is a significant problem after solid-organ transplantation
    Kawaguchi S.
    Maniruzzaman M.
    Katsuragi K.
    Matsumoto H.
    Iriany I.
    Ito K.
    Hugenberg N.
    Schmidt M.
    Drugs & Therapy Perspectives, 2002, 18 (12) : 19 - 21
  • [50] NEW IMMUNOSUPPRESSIVE DRUGS IN TRANSPLANTATION
    GROTH, CG
    OHLMAN, S
    GANNEDAHL, G
    ERICZON, BG
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (04) : 2681 - 2683
12345